医学
细菌性肺炎
肺炎
抗生素
社区获得性肺炎
微生物学
重症监护医学
内科学
生物
作者
Roman Stets,Monica Popescu,Joven Gonong,Ismail Mitha,William Nseir,Andrzej Madej,Courtney Kirsch,Anita Das,Lynne Garrity-Ryan,Judith N. Steenbergen,Amy Manley,Paul B. Eckburg,Evan Tzanis,Paul C. McGovern,Evan Loh
标识
DOI:10.1056/nejmoa1800201
摘要
Omadacycline was noninferior to moxifloxacin for the treatment of community-acquired bacterial pneumonia in adults. (Funded by Paratek Pharmaceuticals; OPTIC ClinicalTrials.gov number, NCT02531438 .).
科研通智能强力驱动
Strongly Powered by AbleSci AI